Delivery Order SPE2DR25D1103-SPE2DR26FD705
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,937.65 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with a completion date of August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $15,954.18 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in 60-dose inhalers. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,064.29 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. This firm fixed-price, non-set-aside delivery order was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $20,134.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract awarded on July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $25,431.01 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-unit supply). This firm fixed-price, non-set-aside contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRELEGY ELLIPTA is a combination respiratory medication commonly prescribed for chronic obstructive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of April 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $20,089.16 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination pulmonary medication supplied in a 60-dose inhaler. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and employs firm fixed price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- The Defense Logistics Agency awarded a $5,065.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 (60 count), a combination maintenance inhaler used in respiratory disease management. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 20, 2025. Work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD705Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a prime contractor with the Defense Logistics Agency's Medical Supply Chain, the company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm fixed pricing model and rapid delivery timeline reflect the operational requirements of the Defense Health Agency and other government healthcare systems that rely on AmerisourceBergen's comprehensive pharmaceutical support capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/31/25 |